Skip to main content
. 2022 Apr 7;2022:2004973. doi: 10.1155/2022/2004973

Table 2.

Measurement of quality-of-life scores (x ± s).

Group n Physical function Emotional function Cognitive function Social function Role function Total score
Before treatment After treatment Before treatment After treatment Before treatment After treatment Before treatment After treatment Before treatment After treatment Before treatment After treatment
Joint group 49 53.22 ± 4.90 82.69 ± 4.66 53.20 ± 4.99 83.04 ± 5.01 56.29 ± 4.56 84.37 ± 4.76 54.29 ± 4.82 85.04 ± 4.46 53.29 ± 5.32 82.86 ± 5.55 54.18 ± 4.89 82.88 ± 5.35
Single-drug group 49 54.27 ± 4.70 67.41 ± 4.88 53.90 ± 4.48 67.47 ± 4.70 57.47 ± 4.62 71.45 ± 4.83 55.12 ± 4.65 69.18 ± 4.17 54.31 ± 4.54 67.88 ± 4.99 54.71 ± 4.35 68.00 ± 4.56
t 1.073 15.86 0.724 15.87 1.277 13.34 0.875 18.18 1.021 14.06 0.568 14.82
P 0.286 ≤0.001 0.471 ≤0.001 0.205 ≤0.001 0.384 ≤0.001 0.310 ≤0.001 0.571 ≤0.001

∗P < 0.01 vs before treatment, P < 0.01 vs joint group.